Lonoctocog alfa

罗诺凝血素α

Report date: 2026/03/31 20:00:21

Base Information

Drug NameLonoctocog alfa
Drug Alias Name单链重组抗血友病因子rVIII-single chain - CSL单链重组凝血因子VIIIrVIII-SingleChain - CSLrVIII-SC - CSL +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/05/25
Country/TerritoryCzechiaCanadaUnited States +[30] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSk ChemicalsCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring AgCsl BehringCsl Behring Gmbh +[5] 
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksN/A